X4 Pharmaceuticals, Inc. buy Cantor Fitzgerald
Start price
31.05.24
/
50%
€0.93
Target price
31.05.25
€4.61
Performance (%)
-82.01%
End price
01.06.25
-
Summary
This prediction is currently being closed. The BUY prediction by Cantor_Fitzgerald for X4 Pharmaceuticals, Inc. is performing very badly with a performance of -82.01%. Cantor_Fitzgerald has a follow-up prediction for X4 Pharmaceuticals, Inc. where he still thinks X4 Pharmaceuticals, Inc. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| X4 Pharmaceuticals, Inc. | - | - | - |
| iShares Core DAX® | -3,52 % | -4,99 % | 1,93 % |
| iShares Nasdaq 100 | 0,26 % | 1,10 % | 15,43 % |
| iShares Nikkei 225® | -4,95 % | -3,35 % | 29,01 % |
| iShares S&P 500 | -0,82 % | -0,04 % | 10,81 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat
In the thread Trading X4 Pharmaceuticals, Inc.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc.
Start price
Target price
Perf. (%)
€0.25
26.03.25
26.03.25
€2.78
26.03.26
26.03.26
-33.95%
25.04.25
25.04.25
